SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
DexCom, Inc. (DXCM) trades at a trailing P/E of 30.1, forward P/E of 25.3. Trailing earnings yield is 3.33%, forward earnings yield 3.95%. PEG 0.64 (Peter Lynch undervalued ≤1.0). Graham Number is $18.59.
Criteria proven by this page:
- VALUE (69/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.64); analyst target implies upside (+36.3%).
- Forward P/E 25.3 (down from trailing 30.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.64 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.33% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 3.95% as earnings recover.
- Analyst consensus target $85.82 (+36.3% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 82/100 with 7/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
69/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DXCM
Valuation Multiples
P/E (TTM)30.1
Forward P/E25.3
PEG Ratio0.64
Forward PEG1.33
P/B Ratio9.16
P/S Ratio5.44
EV/EBITDA19.3
Per Share Data
EPS (TTM)$2.16
Forward EPS (Est.)$2.49
Book Value / Share$7.10
Revenue / Share$12.06
FCF / Share$2.79
Yields & Fair Value
Earnings Yield3.33%
Forward Earnings Yield3.95%
Dividend Yield0.00%
Graham Number$18.59
SharesGrow IV$98.26 (+56.1%)
Analyst Target$85.82 (+36.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
-76.1 |
-6.85 |
17.59 |
8.71 |
- |
| 2017 |
-98.7 |
3.95 |
11.81 |
6.89 |
- |
| 2018 |
-83.1 |
-0.59 |
15.93 |
10.24 |
- |
| 2019 |
197.1 |
-1.11 |
22.58 |
13.50 |
- |
| 2020 |
70.7 |
0.19 |
19.11 |
18.11 |
- |
| 2021 |
239.5 |
-4.18 |
25.43 |
21.21 |
- |
| 2022 |
129.2 |
2.26 |
20.68 |
15.15 |
- |
| 2023 |
88.5 |
1.39 |
23.16 |
13.22 |
- |
| 2024 |
54.6 |
39.32 |
14.97 |
7.80 |
- |
| 2025 |
31.0 |
0.66 |
9.43 |
5.56 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.20 |
$573.3M |
$-65.6M |
-11.4% |
| 2017 |
$-0.15 |
$718.5M |
$-50.2M |
-7% |
| 2018 |
$-0.36 |
$1.03B |
$-127.1M |
-12.3% |
| 2019 |
$0.27 |
$1.48B |
$101.1M |
6.8% |
| 2020 |
$1.27 |
$1.93B |
$493.6M |
25.6% |
| 2021 |
$0.36 |
$2.45B |
$154.7M |
6.3% |
| 2022 |
$0.80 |
$2.91B |
$341.2M |
11.7% |
| 2023 |
$1.30 |
$3.62B |
$541.5M |
14.9% |
| 2024 |
$1.42 |
$4.03B |
$576.2M |
14.3% |
| 2025 |
$2.09 |
$4.66B |
$836.3M |
17.9% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$2.49 |
$2.38 – $2.56 |
$5.23B |
$5.19B – $5.35B |
15 |
| 2027 |
$2.99 |
$2.75 – $3.31 |
$5.86B |
$5.78B – $6.09B |
14 |
| 2028 |
$3.59 |
$3.20 – $3.99 |
$6.57B |
$6.55B – $6.58B |
6 |
| 2029 |
$4.26 |
$4.18 – $4.43 |
$7.48B |
$7.38B – $7.72B |
4 |
| 2030 |
$5.02 |
$4.93 – $5.22 |
$8.6B |
$8.48B – $8.87B |
2 |
